HOME - Well That Makes Sense

“Damn, there is so much great knowledge out there. Did you know that “BOOKS” are full of smart?? No, I mean like life changing, I-wish-I-knew-that-years-ago type stuff.

I know that I was waaaayyy late to the game figuring it out. And I know that a lot of you are too busy to read as much as you ‘should’. And that is why you need me.

I still remember how it started for me. It started in June of 2008. After 11 years …..Click to continue

Mortgage Today (AM) - 10/27/26

{{catlist}}
October 27, 2026

**WTMS Blog Today = What's up in Mortgage Today (AM) - 10/27/2026** The mortgage industry is stuck in a vise: rates near 5 percent keep borrowers on the sidelines while builder confidence hits its lowest level since 2012. Non-QM and ARM products are filling the volume gap as loan officers navigate a market that rewards speed and flexibility over traditional conforming strategies. UMBS securities weakened mid-week but recovered, reflecting the tension between safe-haven demand and persistent inflation concerns tied to elevated oil prices above $100 per barrel. Capital markets remain cautious ahead of this week's FOMC decision, with traders pricing roughly an 80 percent probability of a December rate hike despite Fed leadership signaling no urgency for an immediate move. President Trump's executive order directing lower GSE mortgage insurance and title costs could eventually ease refinance friction, though implementation timelines remain uncertain and wide industry interpretation persists. Loan officers and branch managers continue to face retention pressures as production economics tighten and alternative channels—wholesale, correspondent, and broker platforms—attract talent with lower cost structures and delegation models. **Locking vs Floating** Borrowers considering locks should act decisively at current levels, as mortgage rates remain structurally sticky above 4.95 percent on the 10-year Treasury. Further rate relief appears constrained unless oil prices retreat sharply or Fed pivot signals emerge, making near-term float risk limited for most scenarios. Rate locks provide certainty in an otherwise volatile week heading into Wednesday's FOMC statement, particularly for closing-sensitive transactions. **Today's Events** September Durable Goods Orders (released, +1.8% vs. +1.9% forecast). August FHFA Housing Price Index. August S&P Case-Shiller Home Price Index. October Consumer Confidence. September New Home Sales. $70 billion 5-year Treasury note auction. **Bond Pricing** **UMBS 30 yr** | Coupon | Price | Intra-Day Change | **GNMA 30 yr** | Coupon | Price | Intra-Day Change | **Treasuries** | Term | Yield | Price | Intra-Day Yield Change |

WTMS Video Summary

▶ Watch Today's Mortgage Market Recap

Gene-Edited War Dogs in Body Armor: The $1.2 Billion Startup That Sounds Like Science Fiction

{{catlist}}
October 27, 2026

linkedin_post_2_200m_investment_gptimage25_2_10.24.26

Gene-Edited War Dogs in Body Armor: The $1.2 Billion Startup That Sounds Like Science Fiction

You probably didn't have "cloned war dogs in high-tech armor" on your 2027 bingo card, but here we are. Two billionaire tech founders just launched a startup that wants to genetically engineer elite military dogs, clone them, and outfit them with advanced battlefield equipment. It sounds like a rejected screenplay, except it's real, it's already raised $200 million, and the first gene-edited puppies are expected in about two years.

The Players Behind This Wild Idea

Warhound is the brainchild of Ben Lamm, who founded Colossal Biosciences (the company working to bring back woolly mammoths), and Palmer Luckey, the Oculus VR creator who now runs Anduril, a defense technology company. Lamm brings the genetic engineering expertise; Luckey brings the military hardware and software. Together, they've convinced investors that genetically optimized dogs in sensor-laden armor represent the future of military and law enforcement operations. The company is already valued at $1.2 billion before it's produced a single animal. That valuation tells you how seriously the defense and biotech worlds are taking this concept, even if it sounds like something from a Marvel movie.

How the Technology Actually Works

The process starts with collecting cells from proven working dogs—military dogs, police K9s, and first-responder animals that have demonstrated exceptional performance in real situations. Warhound's scientists will edit the genomes of these cells to remove genes associated with inherited health problems and potentially add genes that enhance desirable traits. Then they'll use cloning technology to create embryos that develop into puppies carrying those modifications. This isn't hypothetical science; the cloning part is established technology that's been used on pets and livestock for years. The gene-editing component uses CRISPR and related tools that are now standard in biotech labs. What's new is applying both techniques specifically to create optimized working dogs at scale.

The Health Improvements Come First

The initial gene edits will target inherited diseases that plague many dog breeds, especially the larger breeds commonly used in military and police work. Hip dysplasia, a painful joint condition, affects roughly 20 percent of German Shepherds and Belgian Malinois—the breeds most commonly used as working dogs. Other targets include heart conditions, certain cancers, and joint problems that force dogs into early retirement or cause chronic pain. Eliminating these conditions would genuinely improve animal welfare, extending working dogs' careers and quality of life. A military dog costs approximately $40,000 to $50,000 to acquire and train, so keeping them healthy and operational longer has real economic value beyond the moral argument. This is the least controversial part of Warhound's mission, and it's where the company will likely start.

The Performance Enhancements Are Where It Gets Complicated

Once the health issues are addressed, Warhound plans to move into enhancement territory—editing genes to improve speed, agility, endurance, and olfactory capability. The company has mentioned potentially incorporating wolf genes to boost certain traits. Wolves can sustain running speeds of about 35 miles per hour and have scent detection abilities that exceed even the best dog breeds. They also have different pain tolerance and pack behavior patterns. This is where the technology shifts from therapeutic to enhancement, from fixing problems to creating capabilities that don't exist in current dogs. It raises questions about what we're creating and why. Are we making better tools, or are we creating animals that exist primarily to serve human military objectives in ways that might compromise their welfare?

The Anduril Hardware Adds Another Layer

Palmer Luckey's Anduril isn't just an investor; the company will develop the physical and software systems these dogs will carry into the field. We're talking about advanced body armor designed specifically for canine anatomy, protective goggles that could include heads-up displays or low-light enhancement, and integrated sensor systems that feed battlefield awareness data to handlers and command centers. Current military dogs already wear some protective gear, but Anduril's track record suggests something far more sophisticated—think networked systems that turn each dog into a mobile sensor platform. The dog becomes both a biological operator and a piece of connected battlefield infrastructure. That integration could save human and canine lives by providing better situational awareness, but it also means these animals are being designed as weapons systems from the genome up.

The Timeline Is Surprisingly Close

Warhound expects its first gene-edited puppies in early 2027—roughly two years from now. That aggressive timeline is possible because both the cloning technology and the gene-editing tools already exist and have been proven in other applications. The company isn't inventing new science; it's combining established techniques in a new context. After those first puppies are born, there will be years of training and evaluation to see if the genetic modifications translate into real-world performance improvements. A military working dog typically requires 18 to 24 months of training before deployment, so we're looking at operational animals around 2029 at the earliest. That's still remarkably fast for a technology that didn't exist as a company until 2026.

The Potential Civilian Benefits Are Real

While Warhound's focus is military and law enforcement, the technology could have significant civilian applications. Search-and-rescue dogs that are healthier, have longer careers, and possess enhanced scent detection could save more lives in disaster scenarios. Detection dogs used in conservation work, at borders for agricultural inspection, or in medical settings for disease detection could all benefit from genetic improvements that make them better at their jobs and healthier throughout their lives. Guide dogs and service animals could be bred without the hereditary conditions that currently force many promising dogs out of training programs. If the technology proves safe and effective, and if it's made available beyond military contracts, the welfare and capability improvements could extend to working dogs across many fields.

The Ethical Questions Can't Be Ignored

Creating animals specifically designed for combat roles through genetic engineering crosses lines we haven't crossed before. We've bred dogs for thousands of years, selecting for traits we wanted, but genetic engineering is more direct, faster, and capable of changes that wouldn't occur through traditional breeding. Are we obligated to consider the animal's experience when we design it to be more aggressive, to tolerate more pain, or to perform in ways that put it in greater danger? The animals can't consent to being created for these purposes. There's also the question of what happens to gene-edited dogs that don't meet performance standards or that are retired from service. Will they be adopted into civilian homes? Are there unforeseen health or behavioral consequences of the modifications? These aren't hypothetical concerns—they're questions that need answers before the first modified puppy is born.

The Military Demand Is Clearly There

The U.S. military currently uses approximately 1,600 working dogs across all branches, with demand consistently exceeding supply. Training programs struggle to produce enough qualified animals, and many dogs wash out due to health problems or temperament issues. If Warhound can reliably produce dogs that are healthier, perform better, and last longer in service, the military market alone would justify the investment. Law enforcement agencies use thousands more K9s, and many face similar supply challenges. The $200 million in funding and the $1.2 billion valuation reflect investor confidence that this demand is real and that Warhound's approach can meet it. Whether that demand should be met through genetic engineering rather than improved breeding and training is a separate question, but the market clearly exists.

What This Means for Genetic Engineering Broadly

Warhound represents genetic engineering moving out of the laboratory and into operational, real-world applications in a very visible way. Colossal Biosciences' work on extinct species is fascinating but abstract; gene-edited military dogs are concrete and immediate. If this succeeds, it will normalize genetic modification of animals for human purposes in ways that could accelerate similar applications elsewhere—agriculture, conservation, medicine, even pets. That's not inherently good or bad, but it's a significant shift. It will force conversations about regulation, oversight, animal welfare standards, and the limits of what we should do just because we can. The technology is moving faster than our ethical frameworks and legal structures, which is often how transformative technologies work, but it means we're figuring out the rules as we go.

The Bottom Line on Gene-Edited War Dogs

This is simultaneously impressive, useful, and deeply strange. The technology could genuinely improve the lives of working dogs by eliminating painful inherited diseases and could enhance their capabilities in ways that save human lives. It could also push us into territory where we're creating sentient beings primarily as optimized tools for combat, with all the ethical complications that entails. The first gene-edited puppies will arrive in about two years, which doesn't leave much time for society to figure out how it feels about this or what guardrails should exist. The science is real, the funding is secured, and the market demand is clear. Whether this is a breakthrough in animal welfare and capability or a troubling step toward treating living beings as programmable hardware depends partly on how Warhound executes and partly on what values we decide to prioritize. What do you think—is genetically engineering working dogs for health and performance a genuine improvement, or does it cross a line we shouldn't cross?

linkedin_post_1_civilian_applications_seedream45_1_10.24.26

Mortgage Today (PM) - 10/26/26

{{catlist}}
October 26, 2026

**WTMS Blog Today = What's up in Mortgage Today (PM) - 10/23/2026** Mortgage rates finally caught a break this week as technology stock turmoil sent investors fleeing to the safety of U.S. Treasury bonds. The 10-year yield dropped sharply from 5.36% to below 4.96%, marking the best day for Treasuries since August 2025 and lifting mortgage-backed securities higher for the first time in weeks. This rally provided meaningful relief after rates had climbed to 20-year highs on persistent inflation fears and geopolitical tensions, though borrowing costs remain elevated by historical standards. Lenders reported improved pricing power as MBS spreads tightened and borrowers who had paused their searches showed renewed interest in locking rates. The AI sector selloff, particularly in companies like Coreweave that heavy investors had bet on for artificial intelligence infrastructure, sparked genuine flight-to-safety demand that overshadowed hawkish Fed signals and hotter-than-expected inflation data. President Trump signed a housing executive order targeting mortgage costs through proactive mortgage insurance cancellation pilots, expanded title insurance alternatives, and reduced loan-level price adjustments on qualifying refinances. The order directs FHFA to make title insurance waivers permanent across both Fannie Mae and Freddie Mac, potentially saving borrowers $500 to $1,500 on refinances. However, the final version narrowed the most ambitious provisions from the draft—the mortgage insurance pilot now applies only to future originations rather than retroactively canceling premiums for existing borrowers based on current valuations. The MBA separately released its own affordability roadmap proposing single-bureau credit reporting for scores above 700, lower annual FHA mortgage insurance premiums, and reduced loan-level price adjustments, estimating borrowers could save $1,000 to $800 annually on respective transactions. Both initiatives acknowledge the affordability crisis while targeting existing homeowners and refinance activity more than first-time buyers struggling with down payments and home prices. Meanwhile, Fannie Mae and Freddie Mac have diverged significantly on artificial intelligence governance requirements that lenders selling to both GSEs must now navigate. Fannie's revised Information Security Supplement employs "Super Intelligence" terminology and takes a stricter principles-based approach to AI model governance, data controls, and technology lifecycles effective January 18, 2027. Freddie Mac's requirements, already in effect since March, remain more prescriptive on audits, executive approvals, and vendor liability frameworks. Lenders cannot simply comply with one GSE's standards and expect alignment with the other, forcing many to redesign policies and vendor agreements before Fannie's deadline. The divergence highlights how rapidly agency expectations are evolving and how compliance costs mount when the two largest mortgage purchasers develop separate AI rulebooks instead of coordinated standards. September mortgage origination volume declined sharply with the MBA reporting total applications down 37.5% year-over-year, pushed lower by rates climbing to 7.5% and a refinance environment offering minimal savings for most borrowers. The MBA's 2027 forecast predicts total origination volume will drop approximately 5% to just under $2 trillion, down from the $2.1 trillion expected in 2026, with purchase originations barely growing at 0.8% while refinances collapse by 17%. Existing home sales data revealed an unprecedented imbalance—home sellers now outnumber buyers by 63%, the widest gap since records began in 2013, with just 928,892 buyers on the market against 1.51 million sellers. Home affordability remains a structural problem, with ATTOM data showing buyers need $90,191 in annual income to purchase a median-priced $368,000 home, roughly $10,657 above average worker wages, and ownership costs consuming nearly 32% of median wages even with 20% down. Real estate credit conditions show stress emerging, with GSE repurchase activity climbing 19.5% in the second quarter and sub-700 FICO loans hitting their highest share of 2026 UMBS issuance at 11.4%. **Locking vs Floating** The bond market's recent rally appears driven more by temporary equity market distress than confirmed fundamental improvement. Investors reduced expectations for Fed rate hikes next year, but that shift remains fragile and could reverse quickly if technology stocks stabilize or new inflation data disappoints. Persistent oil prices above $110 per barrel, elevated Treasury issuance, and foreign capital outflows keep upward pressure on longer-term yields. Borrowers closing within 30 days should strongly consider locking rates at current levels rather than floating into the Q4 closeout period when demand may spike and margins compress. **Today's Events** Core PPI Month-over-Month (September): 0.7% vs. 0.3% forecast, 0.2% prior Building Permits: 1.400M vs. 1.390M forecast Housing Starts: 1.221M vs. 1.300M forecast **Bond Pricing** **UMBS 30 yr** | Coupon | Price | Intra-Day Change | **GNMA 30 yr** | Coupon | Price | Intra-Day Change | **Treasuries** | Term | Yield | Price | Intra-Day Yield Change |

Market Data

RECENT ARTICLES

Send me some brain food

We will Put More Awesome Stuff
In Your Brain